轮状病毒疫苗对菲律宾腹泻住院与门诊就诊的影响:首个来自中等收入亚洲国家的证据
菲律宾自2012年起分阶段引入单价轮状病毒疫苗。该回顾性研究在已引入疫苗的Agusan del Sur的D.O. Plaza医院(2009-2016年)和未引入疫苗的Cotabato Regional Medical Center(2011-2016年)回顾医生诊断的腹泻住院记录,并获取Agusan del Sur公共卫生诊所门诊咨询报告及疫苗覆盖率。结果显示,DOPH五岁以下儿童全因腹泻住院在2013-2016年较2009-2011年基线均值下降28%至63%,门诊咨询下降27%至67%,而CRMC未见明显下降;作者认为疫苗引入与腹泻住院和门诊咨询大幅下降相关。
要点
- DOPH五岁以下儿童全因腹泻住院2013-2016年较2009-2011年基线均值下降28%-63%。
- Agusan del Sur公共卫生诊所腹泻门诊咨询2013-2016年下降27%-67%。
- 未引入疫苗地区CRMC 2011-2016年腹泻住院未见明显下降。
核心结论
- 轮状病毒疫苗引入与菲律宾Agusan del Sur腹泻住院和门诊咨询大幅下降相关。
研究设计与样本
- 回顾性综述,在已引入轮状病毒疫苗的Agusan del Sur的D.O. Plaza医院(2009-2016年)和未引入疫苗的Cotabato Regional Medical Center(2011-2016年)回顾医生诊断的腹泻住院记录,并获取Agusan del Sur公共卫生诊所门诊咨询报告及疫苗覆盖率。
主要发现
- DOPH五岁以下儿童全因腹泻住院以2009-2011年均值(X‾=1,141)为基线,2013年下降28%(n=821)、2014年下降56%(n=507)、2015年下降63%(n=417)、2016年下降59%(n=466)。
- CRMC 2011-2016年腹泻住院未见明显下降。
- Agusan del Sur门诊咨询2013年下降27%(n=2,333)、2014年下降33%(n=2,143)、2015年下降45%(n=1,764)、2016年下降67%(n=1,059)。
- 2012年9月至2016年12月,1剂和2剂轮状病毒疫苗覆盖率从2012年的5%和4%逐渐升至2015年的92%和88%,2016年分别降至53%和52%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Monovalent rotavirus (RV) vaccine was introduced in the Philippines in a phased manner beginning in 2012. To assess the impact of RV vaccine, we conducted a retrospective review of diarrheal admissions in two hospitals. METHODS: Records of physician-diagnosed diarrheal admissions were reviewed in D.O. Plaza Hospital (DOPH) from 2009 to 2016 in Agusan del Sur where RV vaccine was introduced in the immunization program; and in Cotabato Regional Medical Center (CRMC) from 2011 to 2016 in a region where the vaccine was not introduced. Reports from consultations in public health clinics in Agusan Del Sur and RV vaccine coverage were obtained. RESULTS: All-cause diarrheal admissions among children <5 years old in DOPH declined from 2013 to 2016 following RV vaccine introduction in 2012. Using the 2009-2011 mean number of hospitalizations as baseline (X‾ = 1,141), the reductions were 28% (n = 821), 56% (n = 507), 63% (n = 417) and 59% (n = 466) in 2013, 2014, 2015 and 2016, respectively. In comparison, no substantial declines in diarrheal hospitalizations were seen in CRMC from 2011 to 2016. A declining trend was also seen in outpatient consultations in Agusan del Sur following RV vaccine introduction with declines of 27% (n = 2,333), 33% (n = 2,143), 45% (n = 1,764) and 67% (n = 1,059) in 2013, 2014, 2015 and 2016. From September 2012 to December 2016, the 1 and 2-dose RV vaccine coverage gradually increased from 5% and 4% in 2012 to 92% and 88% in 2015, but decreased in 2016 to 53% and 52%, respectively. DISCUSSION: RV vaccine introduction was associated with a substantial decline in diarrheal hospitalizations and outpatient consultations for diarrhea in Agusan del Sur, Philippines.
引用
- Lopez AL, Raguindin PF, Esparagoza J, et al. Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country. Vaccine. 2018. PMID: 29729994. doi:10.1016/j.vaccine.2018.04.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。